Melola Discovery

← Melola Discovery

Jurnal

Phytochemical and Pharmacological Review of Arcangelisia flava (L.) Merr: Insights into Its Bioactive Compounds and Therapeutic Potential

JURNAL BIOLOGI PAPUA · Vol. 17 No. 1 (2025) · pp. 82–92

DOI
10.31957/jbp.4508
ISSN
2503-0450, 2086-3314
Published
2025-06-12
Publisher
Jurusan Biologi FMIPA Universitas Cenderawasih
Language
eng

Abstract

Arcangelisia flava (L.) Merr., commonly known as kayu kuning, is a medicinal plant traditionally used in Southeast Asian medicine. Various studies have identified bioactive compounds such as furanoditerpenes, alkaloids, flavonoids, tannins, and phenolic compounds that contribute to its pharmacological activities, including antimicrobial, antioxidant, and antidiabetic effects. Despite the growing body of research on its pharmacological potential, the mechanisms of action of these bioactive constituents remain inadequately understood, and clinical evidence supporting its use in modern therapy is still limited. This systematic review compiles data from diverse scientific sources, focusing on the phytochemical composition, extraction methods, pharmacological activities, and comparisons with conventional pharmaceutical agents. The analysis revealed that A. flava contains various bioactive constituents responsible for its therapeutic effects. Furanoditerpenes demonstrate antimicrobial and antifungal activity, while alkaloids and phenolic compounds exhibit significant antioxidant and antidiabetic properties. Extraction techniques varied across studies, affecting the efficiency of bioactive compound isolation. Comparisons with standard pharmaceuticals suggest that A. flava extracts exhibit comparable efficacy in several pharmacological domains. These findings indicate that A. flava holds considerable promise as a natural therapeutic agent. However, further investigations are needed to clarify its pharmacological mechanisms through pharmacokinetic and pharmacodynamic studies, as well as clinical trials to confirm its safety and effectiveness in human applications. The integration of modern technological approaches such as metabolomics and bioinformatics could facilitate the identification, standardization, and development of phytopharmaceutical products derived from A. flava, thereby advancing its potential use in evidence-based medicine.

Keywords

Collaboration network of the authors

23 authors · 54 co-authorship links

Hover or tap a name to highlight its co-authors. Double-click to open the author's page.

  • Affiliation unknown
  • Different organisations
  • Same organisation
  • Affiliation unknown
  • Thicker line = more joint articles · bigger circle = more articles
Show as table
Co-authorOrganisationJoint articles
Rani D. PratiwiAffiliation unknown3
Maria T. NainggolanAffiliation unknown2
Verena AgustiniAffiliation unknown2
Dirk Y.P. RuntuboiAffiliation unknown1
Agustina RubanAffiliation unknown1
Yati B. YuliatiAffiliation unknown1
Dadang SupriyatnaAffiliation unknown1
Rusnaeni RusnaeniAffiliation unknown1
Elsye GunawanAffiliation unknown1
Jane AwomAffiliation unknown1
Susan WopiAffiliation unknown1
Supeni SufaatiAffiliation unknown1
Agnes E. MaryuniAffiliation unknown1
Diana M. AbulaisAffiliation unknown1
Johnson SiallaganAffiliation unknown1
Martha K. SefaAffiliation unknown1
Lodwyk N. KrimadiAffiliation unknown1

Affiliations come from OpenAlex; journal OAI-PMH metadata carries none. Authors without an OpenAlex ID are matched by name, which can merge or split people.

Metadata source: OAI-PMH (metadata jurnal) https://ejournal.uncen.ac.id/index.php/JBP/oai, first harvested 1 Nov 2026, last seen 1 Nov 2026.
Original metadata (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Phytochemical and Pharmacological Review of Arcangelisia flava (L.) Merr: Insights into Its Bioactive Compounds and Therapeutic Potential</dc:title>
	<dc:creator>Yabansabra, Yuliana Rut</dc:creator>
	<dc:creator>Bowaire, Anike</dc:creator>
	<dc:creator>Simaremare, Eva S.</dc:creator>
	<dc:creator>Yaam, Demas R.</dc:creator>
	<dc:creator>Tiris, Aira</dc:creator>
	<dc:creator>Nadeak, Erpina S.M.</dc:creator>
	<dc:subject xml:lang="en-US">A. flava</dc:subject>
	<dc:subject xml:lang="en-US">antimicrobial </dc:subject>
	<dc:subject xml:lang="en-US">antioxidant </dc:subject>
	<dc:subject xml:lang="en-US">antidiabetic </dc:subject>
	<dc:subject xml:lang="en-US">phytochemistry</dc:subject>
	<dc:description xml:lang="en-US">Arcangelisia flava (L.) Merr., commonly known as kayu kuning, is a medicinal plant traditionally used in Southeast Asian medicine. Various studies have identified bioactive compounds such as furanoditerpenes, alkaloids, flavonoids, tannins, and phenolic compounds that contribute to its pharmacological activities, including antimicrobial, antioxidant, and antidiabetic effects. Despite the growing body of research on its pharmacological potential, the mechanisms of action of these bioactive constituents remain inadequately understood, and clinical evidence supporting its use in modern therapy is still limited. This systematic review compiles data from diverse scientific sources, focusing on the phytochemical composition, extraction methods, pharmacological activities, and comparisons with conventional pharmaceutical agents. The analysis revealed that A. flava contains various bioactive constituents responsible for its therapeutic effects. Furanoditerpenes demonstrate antimicrobial and antifungal activity, while alkaloids and phenolic compounds exhibit significant antioxidant and antidiabetic properties. Extraction techniques varied across studies, affecting the efficiency of bioactive compound isolation. Comparisons with standard pharmaceuticals suggest that A. flava extracts exhibit comparable efficacy in several pharmacological domains. These findings indicate that A. flava holds considerable promise as a natural therapeutic agent. However, further investigations are needed to clarify its pharmacological mechanisms through pharmacokinetic and pharmacodynamic studies, as well as clinical trials to confirm its safety and effectiveness in human applications. The integration of modern technological approaches such as metabolomics and bioinformatics could facilitate the identification, standardization, and development of phytopharmaceutical products derived from A. flava, thereby advancing its potential use in evidence-based medicine.</dc:description>
	<dc:publisher xml:lang="en-US">Jurusan Biologi FMIPA Universitas Cenderawasih</dc:publisher>
	<dc:date>2025-06-12</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://ejournal.uncen.ac.id/index.php/JBP/article/view/4508</dc:identifier>
	<dc:identifier>10.31957/jbp.4508</dc:identifier>
	<dc:source xml:lang="en-US">JURNAL BIOLOGI PAPUA; Vol. 17 No. 1 (2025); 82-92 </dc:source>
	<dc:source xml:lang="id-ID">Jurnal Biologi Papua; Vol 17 No 1 (2025); 82-92 </dc:source>
	<dc:source>2503-0450</dc:source>
	<dc:source>2086-3314</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://ejournal.uncen.ac.id/index.php/JBP/article/view/4508/3212</dc:relation>
</oai_dc:dc>